Audet & Partners, LLP has learned that Covidien, a medical device manufacturer that supplied material to C.R. Bard that was incorporated into transvaginal mesh products, recently announced that they will set aside $180 million to cover losses expected in connection with transvaginal mesh lawsuits.
Thousands of vaginal mesh lawsuits are currently pending against C.R. Bard in federal multidistrict litigation centered in West Virginia. There is speculation that C.R. Bard may soon settle many of these claims, and the company would then be... Read More